|
Status |
Public on May 20, 2016 |
Title |
SLNCR1 cons rep1 |
Sample type |
SRA |
|
|
Source name |
A375_SLNCR1_conserved
|
Organism |
Homo sapiens |
Characteristics |
cell line: A375 tissue: skin disease: malignant melanoma
|
Treatment protocol |
Cells were transfected with pcDNA3.1(-) empty vector control, or vector expressing SLNCR1, SLNCR1 delta conserved, or SLNCR1 conserved 24 hours post-seeding using Lipofectamine 2000 (Invitrogen).
|
Growth protocol |
A375 cells were maintained in DMEM plus 10% FBS.
|
Extracted molecule |
total RNA |
Extraction protocol |
Cells were harvested 48 hours post-transfection RNA was isolated using Trizol® (Life Technologies) and Qiagen RNeasy Mini Kit and treated with DNase. RNA was selected using NEBNext® PolyA mRNA Magnetic Isolation Module and libraries were prepared using NEBNext® Ultra™ RNA Library Prep Kit for Illumina®.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina NextSeq 500 |
|
|
Description |
processed data file: SLNCR1cons_vs_vector.deseq.txt
|
Data processing |
Read alignment to the hg19 reference genome/transcriptome was performed with STAR (http://bioinformatics.oxfordjournals.org/content/29/1/15). Raw sequence files converted to base-calls by the sequencer software Sequencing reads aligning to unique exons are summed within each gene locus. Counting is performed by featureCounts software (http://bioinformatics.oxfordjournals.org/content/30/7/923.full.pdf). Reads located in regions where genomic features overlap are ignored since they cannot be definitively assigned to a single transcript. Read-count normalization is performed by DESeq software (http://genomebiology.com/2010/11/10/R106/). Genome_build: hg19 Supplementary_files_format_and_content: tab delimited text files including GeneID, BaseMean(Average), BaseMean Replicate1, BaseMean Relicate2, fold change, Log2 fold change, p-value and adjusted p-value. For these DESEq output files, Basemean A refers to vector only while Basemean B refers to expression of either SLNCR1, SLNCR1 delta cons or SLNCR1 cons (as denoted in the file title).
|
|
|
Submission date |
Feb 13, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Carl Novina |
E-mail(s) |
[email protected]
|
Organization name |
Dana-Farber Cancer Institute
|
Department |
Cancer Immunology
|
Lab |
Carl Novina
|
Street address |
450 Brookline Ave
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02115 |
Country |
USA |
|
|
Platform ID |
GPL18573 |
Series (2) |
GSE77901 |
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 |
GSE77903 |
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells |
|
Relations |
SRA |
SRX1584396 |
BioSample |
SAMN04504683 |